| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.8B | $1.8B | $1.8B | $1.8B | $1.6B | $1.5B | $0.5B | $0.5B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | $0.6B |
| Net Income | $0.9B | $0.1B | $0.1B | $-0.3B | $0.2B | $-0.3B | $3.1B | $0.4B |
| EPS (Basic) | $4.40 | $0.04 | $0.23 | $-2.13 | $0.53 | $-1.83 | $1.01 | $0.53 |
| EPS (Diluted) | $4.20 | $0.04 | $0.23 | $-2.13 | $0.53 | $-1.83 | $1.01 | $0.53 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.5B | $16.0B | $16.2B | $16.5B | $17.3B | $16.2B | $18.3B | $17.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.8B | $0.7B | $1.0B | $0.9B | $1.8B | $1.6B | $1.5B | $0.6B |
| Total Liabilities | $8.7B | $9.8B | $9.8B | $10.0B | $10.1B | $8.7B | $10.1B | $11.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $6.0B | $5.2B | $5.5B | $5.8B | $6.2B | $6.5B | $6.7B | $4.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.3B | $0.5B | $0.6B | $0.8B | $0.8B | $0.4B | $0.7B | $0.8B |
| Investing Cash Flow | $0.1B | $-0.6B | $-0.1B | $-0.9B | $-0.5B | $-0.1B | $2.5B | $-0.9B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.3B | $-0.3B | $-0.3B | $-0.8B | $-0.0B | $-0.2B | $-2.2B | $-1.1B |